Volume 6, Number 5—October 2000
Dispatch
Antimicrobial-Drug Use and Changes in Resistance in Streptococcus pneumoniae
Table 2
Class/tertile | Mean | Median | Range | SD |
---|---|---|---|---|
Beta-lactams | ||||
High | 1,640 | 1,620 | 1,186-2,557 | 411 |
Intermediate | 1,027 | 1,040 | 948-1,136 | 69 |
Low | 859 | 870 | 777-917 | 51 |
Macrolides | ||||
High | 929 | 865 | 800-1,286 | 166 |
Intermediate | 738 | 722 | 687-787 | 35 |
Low | 609 | 623 | 528-673 | 52 |
Quinolones | ||||
High | 282 | 258 | 222-424 | 63 |
Intermediate | 197 | 200 | 177-216 | 16 |
Low | 143 | 146 | 91-170 | 27 |
Tetracyclines | ||||
High | 77 | 75 | 61-100 | 15 |
Intermediate | 56 | 58 | 50-59 | 3 |
Low | 33 | 34 | 25-45 | 7 |
aAll values are expressed in units of mean number of prescriptions per 100,000 population per month during the period between the two surveillance studies (May 1994-April 1998).
Page created: December 17, 2010
Page updated: December 17, 2010
Page reviewed: December 17, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.